ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma

Wang, Hang; Yu, Liang; Cui, Yunfu*; Huang, Jiaxin*哈尔滨医科大学
DISEASE MARKERS2022-5-31DOI: 10.1155/2022/1313359
4被引5阅读
引用收藏
分享

摘要

Hepatocellular carcinoma (HCC) is one of the malignancies with an extremely inferior prognosis in the abdominal cavity, making it essential to develop more effective biomarkers for HCC. Although GNG5 has been linked to increased patient survival in a variety of human malignancies, no evidence has been found for its involvement in the development of HCC yet. Our study first analyzed the expression and prognosis of GNG5 in HCC using The Cancer Genome Atlas database (TCGA database) with the Gene Expression Omnibus database (GEO database) and found that GNG5 has a potential oncogenic role. Based on survival analysis, the clinical importance and prognostic value of the GNG5 gene were studied. Relying on tumor Immune Estimation Resource database (TIMER database), we analyzed the correlation between the GNG5 gene and HCC Immune infiltration cells. GNG5 expression levels were significantly higher in HCC tissues compared to normal liver tissues. HCC patients with high GNG5 expression had significantly reduced overall survival time and affected multiple immune cell infiltrates. Additionally, KEGG functional enrichment analysis indicated the PI3K-Akt signaling pathway as the most promising carcinogenic pathway associated with GNG5. This is the first comprehensive revelation of GNG5 as a possible new biological marker associated with immune infiltration in HCC. Additionally, it holds promise as an emerging target for HCC immunotherapy.

相关
加载中…
  • Overexpression of GIHCG is Associated with a Poor Prognosis and Immune Infiltration in Hepatocellular Carcinoma
    Xiao, Siyu; Huang, Shanzhou; Yang, Jie*OncoTargets and Therapy, 2020, 13: 11607-11619.被引 11
  • Poor Prognostic Biomarker KIAA1522 Is Associated with Immune Infiltrates in Hepatocellular Carcinoma
    Shi, Yongjie; Xiao, Qiwen; Huang, Sicong; Pan, Qimou; Jia, Hongyun; Zhou, Qiang; Wei, Jie; Kang, Jiale; Li, Zhe*; Hu, Yingyu*Journal of Oncology, 2023, 2023: 3538928.被引 1
  • CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma
    Zou, Yiping; Ruan, Shiye; Jin, Liang; Chen, Zhihong; Han, Hongwei; Zhang, Yuanpeng; Jian, Zhixiang; Lin, Ye; Shi, Ning*; Jin, Haosheng*MEDICAL SCIENCE MONITOR, 2020, 26: e925289.被引 60
查看全部 →

发表信息

论文状态
公开发表
期刊
DISEASE MARKERS
发表日期
2022-05-31
卷期
第 2022 卷
页码
1313359
DOI
10.1155/2022/1313359
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
Hubei Chen Xiaoping Science and Technology Development Foundation Special Fund for Tumor Prevention and Treatment Research in Sophora [CXPJJH11800004-003]

作者

  • W

    Wang, Hang (第一作者)

    harbin med univ · 2

  • Y

    Yu, Liang

    harbin med univ · 2 · univ hong kong

查看全部 4 位作者收起作者
  • C

    Cui, Yunfu (通讯)

    2 · harbin med univ

  • H

    Huang, Jiaxin (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417